Memory B cell dysregulation in HIV-1-infected individuals

被引:10
|
作者
Carrillo, Jorge [1 ]
Negredo, Eugenia [2 ]
Puig, Jordi [2 ]
Manuel Molinos-Albert, Luis [1 ]
Luisa Rodriguez de la Concepcion, Maria [1 ]
Curriu, Marta [1 ]
Massanella, Marta [1 ]
Navarro, Jordi [3 ]
Crespo, Manel [4 ]
Vinets, Ester [5 ]
Milla, Fuensanta [5 ,6 ]
Clotet, Bonaventura [1 ,2 ,7 ,8 ]
Blanco, Julia [1 ,8 ,9 ]
机构
[1] Hosp Germans Trias i Pujol, HIVACAT, IrsiCaixa AIDS Res Inst, Badalona, Spain
[2] Hosp Germans Trias i Pujol, Fundacio Lluita Sida, Badalona, Spain
[3] Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain
[4] Complexo Hosp Univ Vigo, IIS Galicia Sur, Internal Med Dept, Infect Dis Unit, Vigo, Spain
[5] Hosp Germans Trias i Pujol, ICO, Hematol Dept, Badalona, Spain
[6] Josep Carreras Leukaemia Res Inst, Badalona, Spain
[7] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain
[8] Univ Vic Univ Cent Catalunya UVic UCC, Vic, Spain
[9] Germans Trias i Pujol Res Inst IGTP, Barcelona, Catalonia, Spain
关键词
apoptosis; antiretroviral treatment; HIV-1; immune system; memory B cells; splenic function; HIV-1; INFECTION; SEROLOGICAL MEMORY; RESPONSES; DISEASE; EXPRESSION; POPULATION; SUBPOPULATIONS; MAINTENANCE; COMPARTMENT; ACTIVATION;
D O I
10.1097/QAD.0000000000001686
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective:To characterize the effect of the HIV-1 infection and antiretroviral treatment (ART) in the human memory B (MEB)-cell compartment.Design:A cross-sectional study was designed to analyze MEB cells of HIV-1(+) ART treated and ART-naive study participants, and uninfected individuals.Methods:Frequency and absolute counts of MEB cell subsets in blood were determined by multicolor flow cytometry. Spontaneous cell death and B-cell proliferative capacity was evaluated in vitro by cell culture and flow cytometry. Splenic function was determined by pitted erythrocytes quantification in HIV-1(+) ART-treated study participants.Results:HIV-1(+) ART-treated individuals did not show functional hyposplenism despite the lack of recovery IgM(+)IgD(+)CD27(+) marginal zone-like B cells. Moreover, two germinal center-dependent MEB cells subsets were also dysregulated in HIV-1(+) individuals: IgM(+)IgD(-)CD27(+) (IgM only) cells were increased, whereas the switched subset (IgM(-)IgD(-)) was reduced in viremic individuals. Althought ART restored the numbers of these populations; the switched MEB cells were enriched in CD27(-) cells, which showed the highest susceptibility to spontaneous cell death ex vivo. In addition, B cells from viremic individuals showed a poor response to B-cell receptor and toll-like receptor 9 stimulation that was circumvented when both stimuli were used simultaneously.Conclusion:B cells from HIV-1(+) study participants show a poor stimulation capacity, that may be bypassed by the proper combination of stimuli, and a dysregulated MEB cell pool that suggest an affectation of the germinal center reaction, only partially normalized by ART. Interestingly, hyposplenism does not explain the lack of recovery of the marginal zone-like B cells in ART-treated HIV-1(+) individuals.
引用
收藏
页码:149 / 160
页数:12
相关论文
共 50 条
  • [31] New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
    Angin, Mathieu
    King, Melanie
    Addo, Marylyn Martina
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (75): : e50244
  • [32] Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection
    Arif, Muhammad Shoaib
    Hunter, James
    Leda, Ana Rachel
    Lopes Zukurov, Jean Paulo
    Samer, Sadia
    Camargo, Michelle
    Galinskas, Juliana
    Kallas, Esper Georges
    Komninakis, Shirley Vasconcelos
    Janini, Luiz Mario
    Sucupira, Maria Cecilia
    Diaz, Ricardo Sobhie
    JOURNAL OF VIROLOGY, 2017, 91 (19)
  • [33] T-CELL RECEPTOR-GAMMA-DELTA REPERTOIRE IN HIV-1-INFECTED INDIVIDUALS
    HINZ, T
    WESCH, D
    FRIESE, K
    RECKZIEGEL, A
    ARDEN, B
    KABELITZ, D
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) : 3044 - 3049
  • [34] Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
    Kawana-Tachikawa, Ai
    Llibre, Josep M.
    Bravo, Isabel
    Escrig, Roser
    Mothe, Beatriz
    Puig, Jordi
    Puertas, Maria C.
    Martinez-Picado, Javier
    Blanco, Julia
    Manzardo, Christian
    Miro, Jose M.
    Iwamoto, Aikichi
    Pozniak, Anton L.
    Gatell, Jose M.
    Clotet, Bonaventura
    Brander, Christian
    PLOS ONE, 2014, 9 (01):
  • [35] Attenuated signaling associated with immune activation in HIV-1-infected individuals
    Leng, QB
    Borkow, G
    Bentwich, Z
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (04) : 464 - 467
  • [36] Underestimated Amoebic Appendicitis among HIV-1-Infected Individuals in Japan
    Kobayashi, Taiichiro
    Watanabe, Koji
    Yano, Hideaki
    Murata, Yukinori
    Igari, Toru
    Nakada-Tsukui, Kumiko
    Yagita, Kenji
    Nozaki, Tomoyoshi
    Kaku, Mitsuo
    Tsukada, Kunihisa
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (01) : 313 - 320
  • [37] IL-7 as a potential therapy for HIV-1-infected individuals
    Nunnari, G
    Pomerantz, RJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1421 - 1426
  • [38] Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
    Aouri, Manel
    Barcelo, Catalina
    Guidi, Monia
    Rotger, Margalida
    Cavassini, Matthias
    Hizrel, Cedric
    Buclin, Thierry
    Decosterd, Laurent A.
    Csajka, Chantal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [39] Role of Hexokinase-1 in the survival of HIV-1-infected macrophages
    Sen, Satarupa
    Kaminiski, Rafal
    Deshmane, Satish
    Langford, Dianne
    Khalili, Kamel
    Amini, Shohreh
    Datta, Prasun K.
    CELL CYCLE, 2015, 14 (07) : 980 - 989
  • [40] Cytokine Expression During Syphilis Infection in HIV-1-Infected Individuals
    Knudsen, Andreas
    Benfield, Thomas
    Kofoed, Kristian
    SEXUALLY TRANSMITTED DISEASES, 2009, 36 (05) : 300 - 304